Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
Titel:
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
Auteur:
Beck, J. Procopio, G. Bajetta, E. Keilholz, U. Negrier, S. Szczylik, C. Bokemeyer, C. Bracarda, S. Richel, D.J. Staehler, M. Strauss, U.P. Mersmann, S. Burock, K. Escudier, B.